These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 7539237)

  • 1. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
    Lygidakis NJ; Konstantinidou T; Pothoulakis J
    Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem.
    Lygidakis NJ; Ziras N; Parissis J
    Hepatogastroenterology; 1995 Apr; 42(2):155-61. PubMed ID: 7672764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
    Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study.
    Lygidakis NJ; Stringaris K; Kokinis K; Lyberopoulos K; Raptis S
    Hepatogastroenterology; 1996; 43(7):212-20. PubMed ID: 8682466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined transarterial targeting locoregional immunotherapy-chemotherapy for patients with unresectable hepatocellular carcinoma: a new alternative for an old problem.
    Lygidakis NJ; Kosmidis P; Ziras N; Parissis J; Kyparidou E
    J Interferon Cytokine Res; 1995 May; 15(5):467-72. PubMed ID: 7544232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study.
    Lygidakis NJ; Sgourakis G; Vlachos L; Raptis S; Safioleas M; Boura P; Kountouras J; Alamani M
    Hepatogastroenterology; 2001; 48(42):1685-91. PubMed ID: 11813601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
    Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S
    Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.
    Nagasue N; Yukaya H; Chang YC; Yamanoi A; Kohno H; Hayashi T; Nakamura T
    Surg Gynecol Obstet; 1990 Sep; 171(3):217-22. PubMed ID: 1696750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
    Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of postoperative hepatic arterial infusion following curative liver resection.
    Lorenz M; Staib-Sebler E; Koch B; Gog C; Waldeyer M; Encke A
    Anticancer Res; 1997; 17(5B):3825-33. PubMed ID: 9427788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency liver resection for ruptured hepatocellular carcinoma complicating cirrhosis.
    Chiappa A; Zbar A; Audisio RA; Paties C; Bertani E; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1145-50. PubMed ID: 10370682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
    Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
    Li JQ; Zhang YQ; Zhang WZ
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.